Commercialization of Personalized Medicines

QuickSTAT Pharma Industry
Over the course of the last decade, there has been an increased emphasis on research and development into personalized medicines including cell, gene and immunotherapy treatments. With a forecasted compounded annual growth rate of 8.74%, the market is expected to reach $149 billion by 2020. This pos...

You need to to access this content.


Not yet a member?

Join GCSG to gain full access to our educational resources and our member directory of more than 600 clinical supply colleagues!

register now see membership features